First in India Fortis Manesar Uses ALPI Tube Technology in Complex Rectal Cancer Surgery

First in India: Fortis Manesar Uses ALPI Tube Technology in Complex Rectal Cancer Surgery

- Innovative faecal diversion system helps rectal cancer patient avoid external stoma bag and second reversal surgery -

Manesar, 10th June, 2026: In a landmark clinical advancement in colorectal cancer care, Fortis Hospital 
Manesar has become the first hospital in India to successfully use the innovative ALPI Tube Faecal Diversion System, improving the quality of life for the 55-year-old Bangladeshi Patient, suffering from 
stage 3 rectal cancer. The complex procedure was led by Dr. Vinay Samuel Gaikwad, Senior Director –
Surgical Oncology, Fortis Hospital Manesar, who utilized the novel technique as part of a roboticassisted cancer surgery.

The patient, Mr. Moyazzem Hossain, had been suffering from persistent rectal pain for nearly five months. Due to lack of advanced treatment in his country, he travelled to India and consulted specialists 
at Fortis Manesar. Detailed investigations - including blood tests, tumour marker evaluation, and a PETCECT scan, revealed a large rectal tumour measuring approximately 13 cm with involvement of 
surrounding tissues, confirming Stage III colorectal cancer. After a detailed evaluation, the patient underwent a robotic-assisted surgery to remove the cancerous part of the rectum and nearby affected tissues.

Traditionally, patients undergoing lower rectal cancer surgery often require a temporary stoma (an 
opening created in the abdomen to divert stool away from the healing surgical site) post the surgery.
While effective in reducing the risk of anastomotic leaks (a surgical connection between two sections of 
the intestine which does not heal properly, causing intestinal contents to leak) stomas can significantly 
impact quality of life and often require an additional surgery for reversal.

In this case, Dr. Vinay Gaikwad and his team adopted an innovative approach by placing an ALPI Tube within the intestine during surgery. The device internally diverts faecal matter away from the newly created colorectal junction, protecting the surgical site during healing without the need for an external stoma bag. The technique not only eliminates the discomfort and lifestyle restrictions associated with a stoma but also avoids a second surgery for stoma closure. The surgery lasted about six hours and involved removing the tumour and affected tissues, followed by reconstruction of the intestine, and placement of the ALPI Tube. The patient recovered well after the procedure and was discharged in a stable condition within six days.

Giving details of the case, Dr. Vinay Samuel Gaikwad, Senior Director, Surgical Oncology, Fortis 
Hospital Manesar said, “For decades, temporary stomas have been considered the standard protective 
measure following low rectal cancer surgeries. While clinically effective, they often carry considerable 
psychological, social and physical burdens for patients. The ALPI Tube offers a promising alternative in 
carefully selected cases by providing internal faecal diversion while preserving patient comfort and 
dignity. This approach has the potential to significantly improve recovery, reduce complications associated with stomas and eliminate the need for a second reversal procedure. If left untreated, the tumour could have progressed further, causing complete intestinal obstruction, severe nutritional deterioration, systemic weakness, and potentially life-threatening complications.”

Abhijit Singh, Facility Director, Fortis Hospital Manesar said, “At Fortis Hospital Manesar, our focus is on 
bringing the latest advancements in medical science to improve patient outcomes and quality of life. The 
successful use of the ALPI Tube Faecal Diversion System marks a significant step forward in colorectal 
cancer surgery, offering patients a safer and more comfortable alternative to temporary stomas. Being 
the first hospital in the country to adopt this innovative technique reflects our commitment to clinical 
excellence, innovation and patient-centric care.”